Nuvation Bio Inc Cash Flow-to-Debt Ratio
Nuvation Bio Inc cash flow-to-debt ratio. Nuvation Bio Inc (NUVB) has a Cash Flow-to-Debt Ratio of -0.01x as of June 2026, meaning its operating cash flow of $-5.07 Million could theoretically repay 0% of its total liabilities ($490.64 Million) in one year. Check NUVB cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Nuvation Bio Inc (2018–2025)
Cash flow-to-debt ratio of Nuvation Bio Inc from 2018 to 2025. Historical debt coverage capacity for Nuvation Bio Inc across 8 annual periods. Check Nuvation Bio Inc (NUVB) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Nuvation Bio Inc Cash Flow-to-Debt Ratio by Year (2018–2025)
Nuvation Bio Inc cash flow-to-debt ratio by year from 2018 to 2025. Year-by-year debt coverage analysis for Nuvation Bio Inc. For the full cash flow conversion analysis, see NUVB cash flow conversion.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.60x | $-173.43 Million | $289.11 Million | ▲ +64.7% |
| 2024 | -1.70x | $-130.41 Million | $76.84 Million | ▲ +59.2% |
| 2023 | -4.16x | $-68.00 Million | $16.36 Million | ▲ +26.2% |
| 2022 | -5.63x | $-96.11 Million | $17.07 Million | ▼ -149.0% |
| 2021 | -2.26x | $-68.19 Million | $30.15 Million | ▲ +58.5% |
| 2020 | -5.45x | $-36.53 Million | $6.71 Million | ▲ +28.6% |
| 2019 | -7.63x | $-24.43 Million | $3.20 Million | ▼ -1016.6% |
| 2018 | -0.68x | $-616.00K | $902.00K | — |